Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1073 | Thyroid (non-cancer) | ECE2018

Serum thyroglobulin as a biomarker of iodine status in pregnant women

Dolores Ollero M. , Anda Emma , Toni Marta , Pablo Martinez Juan , Espada Mercedes , Javier Pineda J.

Serum thyroglobulin (Tg) is a biomarker used to assess iodine nutrition status, but data in pregnant women are scarce.Objectives: To determine serum Tg concentration in Spanish healthy pregnant women, and to evaluate its relation with yoduria (UIC), thyroid volume, iodine intake and thyroid function throughout pregnancy.Methods: Longitudinal study in pregnant women with no history of thyroid disease, recruited in 2 obstetric center...

ea0056ep34 | Calcium and Bone | ECE2018

Bone mineral density and polymorphisms of the estrogen receptor gene,vitamin D receptor gene and collagen typei alpha 1 gene

Botella Martinez Sonsoles , Restituto Patricia , Ignacio Monreal , Calleja Amparo , Varo Nerea , Rodriguez Macarena

Objectives: The aim of this study was to analyze the prevalence of some polymorphisms of the CTR-AluI, VDR-FokI, Col1A1y ER-α genes, (involved in bone metabolism), in our population. And evaluate the association of these polymorphisms with bone mineral density and fracture.Design, Patients, and Setting: We performed an observational prospective study in pre- and postmenopausal ambulatory women (n=72 and n=152, respectively).<p ...

ea0056ep187 | Thyroid | ECE2018

Case report and literature review. surgical management of hyperthyroidism in pregnancy

Lomba Alin Abreu , Santrich Melanie , Bastidas Claudia , Perdomo Gustavo , cifuentes rodrigo , Martinez Diana Milena

Hyperthyroidism during pregnancy is determined by decreased thyroid stimulating hormone (TSH), and high levels of thyroid hormones: thyroxine (T4), triiodothyronine (T3), being a complication in 1–2 women per 1,000 pregnancies, and occurs first as Graves’ disease in 0.1–1% of pregnancies. There are specific reference ranges of THS and free T4 for each population and each trimester. For the medical management in the first trimeste...

ea0097024 | Section | BES2023

A case of calcitriol-mediated hypercalcemia in a patient with solid tumor

M. Lomre , N. Sirtaine , K. Van Den Eynde , P. Kleynen , C. Martinez-Mena , K.G. Poppe

Case report: A 50-year-old man was referred by his family doctor to the emergency room in September 2020 for intermittent abdominal pain in the right upper quadrant for several months. He also mentioned weight loss and several episodes of fever with chills. The patient was an active smoker, consumed large amounts of alcohol, and had no known medical history, nor taking any medication. At physical examination, the patient appeared pale and cachectic, with tende...

ea0081oc2.2 | Oral Communications 2: Adrenal and Cardiovascular Endocrinology 1 | ECE2022

Loss of SUMO-specific protease 2 leads to adrenal insufficiency limited to glucocorticoids

Dufour Damien , Dumontet Typhanie , Sahut-Barnola Isabelle , Onzon Meline , Pussard Eric , Wilmouth Jr James , Olabe Julie , Levasseur Adrien , Bossis Guillaume , Yeh Edward , Val Pierre , Martinez Antoine , Anne-Marie Lefrancois-Martinez

The adrenal gland produces corticosteroids essential for hydromineral and metabolic homeostasis. It is organised, in mice, in two concentric layers. The zona glomerulosa (zG) and fasciculate (zF), renewed from progenitors located in the capsular periphery. Centripetal renewal and maintenance of cortical zonation are dependant of a balance between WNT/β-catenin and ACTH/PKA signalling pathways. They provide recruitment and consecutive differentiation of progenitors into zG...

ea0081p381 | Endocrine-Related Cancer | ECE2022

A metastatic ACC mouse model: Combined inactivation of Znrf3 & Tp53 results in consistent adrenocortical carcinoma formation

Wilmouth James , Olabe Julie , Pucheu Laly , Florence Roucher , Rodrigues Cecily Lucas , Soubeyrand-Damon Christelle , Matthias Kroiss , Landwehr Laura-Sophie , Fassnacht Martin , Lefrancois-Martinez Anne-Marie , Martinez Antoine , Val Pierre

Adrenocortical carcinoma (ACC) is an infrequent and aggressive cancer that originates from steroidogenic cells within the adrenal cortex. Half of patients present with metastatic spread at initial diagnosis, and to date, there is no curative therapy for advanced disease. Recent genomic analysis has established that the most aggressive subgroup of ACC patients have overlapping alterations in the WNT/B-catenin pathway and the p53/RB pathway. We therefore set out to develop a met...

ea0081p389 | Endocrine-Related Cancer | ECE2022

Znrf3 inactivation leads to a sexually dimorphic immune microenvironment in adrenocortical tumorigenesis

Olabe Julie , James Wilmouth , Kaitlin Basham , Cecily Lucas , Florence Roucher-Boulez , Igor Tauveron , Anne-Marie Lefrancois-Martinez , Laura-Sophie Landwehr , Matthias Kroiss , Martin Fassnacht , Gary Hammer , Antoine Martinez , Pierre Val

Adrenocortical carcinoma (ACC) is a rare and aggressive cancer that originates from steroidogenic cells within the adrenal cortex. The most common alteration in ACC patients is inactivation of the transmembrane E3 ubiquitin-ligase Zinc and Ring Finger 3 (ZNRF3), which is responsible for inhibiting the canonical WNT/Beta-catenin pathway. Using Cre/loxP strategy, we showed that inactivation of Znrf3 in the adrenal cortex resulted in an initial hyperplasia by 6-weeks, af...

ea0081p766 | Late-Breaking | ECE2022

Diagnostic process in a lipodystrophic syndrome suspition, a clinical case

Ferreira Pablo , Martinez de la Cruz Paula , Miren Azkutia Uribe Echevarria Ane , Shabaka Fernandez Amir , Lois Chicharro Pablo , Carolina Doejo Marciales Sandra , Fabiola Barra Malig Solange , Garmendia Fernandez Cristina , Almodovar Ruiz Francica , Jose Gorgojo Martinez Juan

The lipodystrophic syndromes are a heterogeneous group of congenital or acquired disorders characterized by either complete or partial lack of adipose tissue with the apparent accumulation of fat in other regions of the body. Their prevalence is low and ranges from 1:200000/500000 and they usually suffer metabolic abnormalities associated with the abnormal distributition of fat such as severe insulin resistance with acantosis and diabetes, progressive liver disease along with ...

ea0083erco2 | Endocrine-related Cancer | EYES2022

Ablation of Znrf3 & Trp53 induces metastatic adrenocortical carcinoma in mice

J. Wilmouth JR , J. Olabe , L. Landwehr , L. Pucheu , D. Dufour , F. Roucher-Boulez , C. Lucas-Rodrigues , D. Garcia-Garcia , C. Damon-Soubeyrand , M. Kroiss , M. Fassnacht , A. Lefrancois-Martinez , A. Martinez , P. Val

Background: Adrenocortical carcinoma (ACC) is an aggressive cancer originating from steroidogenic cells within the adrenal cortex. Unfortunately, half of patients present with metastatic spread upon initial diagnosis, and there is no curative therapy for advanced disease. Genomic analysis has identified that the most aggressive subgroup of ACC patients have overlapping alterations in the WNT/β-catenin pathway and the p53/RB signaling pathway.Objecti...

ea0090p389 | Endocrine-related Cancer | ECE2023

Therapeutic potential of the splicing factor SRSF6 as a novel regulator of the Androgen Receptor in prostate cancer

Montero-Hidalgo Antonio J. , Gomez-Gomez Enrique , Saez-Martinez Prudencio , Fuentes-Fayos Antonio C. , Sanchez-Sanchez Rafael , Olmos David , Jesus Martinez-Fuentes Antonio , Sarmento-Cabral Andre , Gahete Manuel D. , Manuel Jimenez Vacas Juan , M Luque Raul

Background: Prostate cancer (PCa) is the fifth leading cause of cancer-related death worldwide. The main pharmacological strategy for this pathology is the blockade of the androgen receptor signalling pathway, commonly known as androgen-deprivation therapy. However, some of the patients does no longer respond to this hormonal therapy. Therefore, finding novel therapeutic strategies to tackle PCa, especially its most advanced phenotype [i.e., castration-resistant prostate cance...